Investigation Timeline & Potential Filings
RosenâŻLawâŻFirmâs announcement onâŻAugustâŻ14âŻ2025 signals the start of a formal securitiesâclassâaction probe into LifeMD, Inc. (LFMD). While the press release does not spell out exact dates, Rosenâs typical procedural cadence provides a useful benchmark: the firm normally completes its initial factsâandâcircumstances review within 30âŻââŻ45âŻdays after the notice of investigation, followed by a 30âday âinvestigation deadlineâ in which they will decide whether to file a formal complaint. In practice, this means a formal filing, if any, is likely to appear between earlyâSeptember and lateâOctoberâŻ2025. Should Rosen decide to proceed, a complaint filing with the U.S. District Court (usually the Southern District of NewâŻYork for NYâbased plaintiffs) would be expected within 60âŻdays of that decisionâso investors should anticipate a potential court filing by late NovemberâŻ2025 at the latest.
Trading Implications
The uncertainty surrounding the exact timing creates a shortâterm âeventâriskâ premium in LFMDâs price. Technically, LFMD has been trading in a narrow, bearish channel (below the 50âday EMA) with the 20âday EMA acting as a resistance level near $4.85. A **break above the 20âday EMA (â$4.90) on volume would suggest the market is discounting the risk, while a breach of the 20âday support (~$4.55) could trigger a sharper decline as investors hedge against a possible classâaction filing.
Actionable Insight
- Shortâterm: Maintain a cautious stance. Consider protective puts or a tight stopâloss (â$4.55) if youâre long, since a filing in the next 2â3âŻmonths could trigger a rapid sellâoff.
- Mediumâterm: If no filing materializes by lateâNovember, the probability of a suit diminishes, supporting a reâentry near the 20âday EMA with a modest buyâonâdip strategy.
- Watch: Rosenâs next public update (expected earlyâSeptember) for any mention of an âinvestigation deadlineââthat will be the first actionable signal for positioning.